Clinical trial
A Phase 1 Pharmacokinetics and Pharmacodynamics of Ketamine Transdermal Drug Delivery System in Subjects With Sub-Optimally Responsive Major Depressive Disorders
NCT03721900 is registered in ClinicalTrials.gov with Shenox Pharmaceuticals, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Pharmacokinetics and Pharmacodynamics of Ketamine Transdermal Drug Delivery System in Subjects With Sub-Optimally Responsive Major Depressive Disorders
- Lead sponsor
- Shenox Pharmaceuticals, LLC
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 28, 2018
- Completion date
- June 6, 2019
- Enrollment
- 14 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.